18,2 386 (16,3%) 502 (21,2%) ( 0,74
Biomolecules 14 , 1520 (2024)
Eid RA, Khalil MA, Alkhateeb MA, Eleawa SM, Zaki MSA, El-Kott AF, Al-Shraim M, El-Sayed F, Eldeen MA, Bin-Meferij MM
The BBB facilitates substances not typically thought of as hormones acting in an endocrine-like fashion, including triglycerides, short-chain fatty acids and lipopolysaccharide
This treatment is a GLP-1 receptor agonist designed to help target the metabolic pathway that controls insulin and blood sugar levels
Product Overview Retatrutide is a synthetic investigational peptide characterized by multi-agonist activity at GIP, GLP-1, and glucagon receptors